Chemical Compound
Meropenem open ring
CAS Registry Number
1053703-36-8
Primary Record
Meropenem open ring
- In stock
- 8,006 g
- Purity
- 98.5 %
- CAS
- 1053703-36-8
Compound Identifiers & Properties
- CAS
- 1053703-36-8
- PubChem CID
- 10069633
- SMILES
- C[C@@H]1[C@@H](NC(=C1S[C@H]2C[C@H](NC2)C(=O)N(C)C)C(=O)O)[C@@H]([C@@H](C)O)C(=O)O
- Canonical SMILES
- C[C@@H](O)[C@@H](C(=O)O)[C@@H]1NC(C(=O)O)=C(S[C@@H]2CN[C@H](C(=O)N(C)C)C2)[C@@H]1C
Names & Synonyms
- Meropenem open ring
- Meropenem EP Impurity A
- Des-(1-Azabicyclo) Meropenem
- UNII-4MC3K7LDC6
- Meropenem Impurity A
- 4MC3K7LDC6
- 1053703-36-8
- RefChem:201625
- Meropenem ring open metabolite
- Meropenem trihydrate impurity A
- SCHEMBL15276204
- C17H27N3O6S
- Meropenem trihydrate impurity A [EP]
- CID10069633
- CID 10069633
- IM178799
- (4R,5S)-5-((1S,2R)-1-Carboxy-2-hydroxypropyl)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid
- H62588
- MEROPENEM TRIHYDRATE IMPURITY A [EP IMPURITY]
- Des-(1-Azabicyclo) Meropenem Disodium Salt (>85%)
- MEROPENEM TRIHYDRATE IMPURITY A (EP IMPURITY)
- (2S,3R)-2-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-4-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-3-methyl-2,3-dihydro-1H-pyrrole-5-carboxylic acid
- (4R,5S)-5-((1S,2R)-1-Carboxy-2-hydroxypropyl)-3-(((3S,5S)-5-((dimethylamino)carbonyl)pyrrolidin-3-yl)sulfanyl)-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid
- (.ALPHA.S,2S,3R)-5-CARBOXY-4-(((3S,5S)-5-((DIMETHYLAMINO)CARBONYL)-3-PYRROLIDINYL)THIO)-2,3-DIHYDRO-.ALPHA.-((1R)-1-HYDROXYETHYL)-3-METHYL-1H-PYRROLE-2-ACETIC ACID
- (alphaS,2S,3R)-5-Carboxy-4-(((3S,5S)-5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-2,3-dihydro-alpha-((1R)-1-hydroxyethyl)-3-methyl-1H-pyrrole-2-acetic acid
- 1H-PYRROLE-2-ACETIC ACID, 5-CARBOXY-4-(((3S,5S)-5-((DIMETHYLAMINO)CARBONYL)-3-PYRROLIDINYL)THIO)-2,3-DIHYDRO-.ALPHA.-((1R)-1-HYDROXYETHYL)-3-METHYL-, (.ALPHA.S,2S,3R)-
- 1H-Pyrrole-2-acetic acid, 5-carboxy-4-(((3S,5S)-5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-2,3-dihydro-alpha-((1R)-1-hydroxyethyl)-3-methyl-, (alphaS,2S,3R)-
- (2~{S},3~{R},4~{S})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-[(3~{S},5~{S})-5-(dimethylcarbamoy l)pyrrolidin-3-yl]sulfanyl-3-methyl-3,4-dihydro-2~{H}-pyrrole-5-carboxylic acid
- (2S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-2H-pyrro le-5-carboxylic acid
- (2S,3R)-2-[(1S,2R)-1-carboxy-2-hydroxy-propyl]-4-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-3-methyl-2,3-dihydro-1H-pyrrole-5-carboxylic acid
- (2S,3R)-2-[(2S,3R)-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfan yl-3-methyl-2,3-dihydro-1H-pyrrole-5-carboxylic acid
- (2S,3R,4S)-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid
- (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-d ihydro-1H-pyrrole-2-carboxylic acid
- (4R,5S)-5-((1S,2R)-1-Carboxy-2-hydroxypropyl)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylicacid
- (4R,5S)-5-[(1S,2R)-1-carboxy-2-hydroxypropyl]-3[[(3S,5S)-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-4-methyl-4,5-dihydro-1H-pyrrole-2- carboxylic acid
- 0RV
- 1H-Pyrrole-2-acetic acid, 5-carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-2,3-dihydro-a-[(1R)-1-hydroxyethyl]-3-methyl-, (aS,2S,3R)-; (aS,2S,3R)-5-Carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-2,3-dihydro-a-[(1R)-1-hydroxyethyl]-3-methyl-1H-pyrrole-2-acetic acid; Imp. A (EP): (4R,5S)-5-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-3-[[(3S,5S)-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic Acid
- 8YL
- DWZ
- LMP
- MER
- N/A